1.
Dargaud Y, Lienhart A, Janbain M, Le Quellec S, Enjolras N, Negrier C. Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab. Haematologica [Internet]. 2018Mar.23 [cited 2026Nov.17];103(4):e181-e183. Available from: https://haematologica.org/article/view/8439